Document is current
Any future updates will be listed below
-
Authors
Slawek, Deepika E.
Althouse, Andrew D.
Feldman, Robert
Arnsten, Julia H.
Bulls, Hailey W.
Liebschutz, Jane M.
Nugent, Shannon M.
Orris, Steven R.
Rohac, Rebecca
Starrels, Joanna L.
Morasco, Benjamin J.
Kansagara, Devan
Merlin, Jessica S.
- License Information
-
More Information
Article History
Received: 22 April 2022
Accepted: 28 June 2023
First Online: 14 July 2023
Declarations
:
: This study was considered exempt from informed consent by the University of Pittsburgh Institutional Review Board because of the study type (“Tests, surveys, interviews, or observation [identifiable]”).This study was considered exempt by the University of Pittsburgh Institutional Review Board and study procedures were performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Dr. Merlin reported grants from Cambia Health Foundation outside the submitted work. Drs. Slawek, Merlin, Arnsten, Starrels, Bulls reported a grant from the National Institutes of Health (NIH) outside the submitted work. Dr. Starrels reported grants from Opioid Post-marketing Requirement Consortium Subcontract for an observational study of the risks of prescription opioids outside the submitted work. Drs. Althouse, Feldman, Liebshutz, Nugent, Orris, Rohac, Morasco, and Kansagara resport no other disclosures.
